The global respiratory care devices market size reached US$ 21.9 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 42.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2023-2032.
Respiratory care devices refer to the medical equipment used for the diagnosis, treatment, assessment and care of patients suffering from pulmonary diseases. Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices. These devices primarily perform diagnostic, therapeutic and monitoring functions. They aid in ensuring a smooth respiration process by providing an adequate amount of oxygen to the lungs and preventing any blockage in the process.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and tuberculosis, represent as the key factors driving the growth of the market. Sedentary lifestyles and stressful routines, in confluence with the growing number of smokers and rate of alcohol consumption, have resulted in rising incidences of lung cancer and other severe respiratory conditions. Also, the increasing number of premature births, along with the growing geriatric population are also impacting the demand for respiratory care devices. Both premature newborns and elderly tend to have weak immune systems and require various breathing support devices for facilitating artificial breathing and preventing respiratory disorders, including newborn respiratory distress syndrome (RDS). Other factors, such as the increasing healthcare expenditure and the development of miniature devices are projected to drive the market further. Significant efforts by both the government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all, along with developing new and improving the existing healthcare infrastructure are also creating a positive outlook for the market.
Respiratory care devices refer to the medical equipment used for the diagnosis, treatment, assessment and care of patients suffering from pulmonary diseases. Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices. These devices primarily perform diagnostic, therapeutic and monitoring functions. They aid in ensuring a smooth respiration process by providing an adequate amount of oxygen to the lungs and preventing any blockage in the process.
The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and tuberculosis, represent as the key factors driving the growth of the market. Sedentary lifestyles and stressful routines, in confluence with the growing number of smokers and rate of alcohol consumption, have resulted in rising incidences of lung cancer and other severe respiratory conditions. Also, the increasing number of premature births, along with the growing geriatric population are also impacting the demand for respiratory care devices. Both premature newborns and elderly tend to have weak immune systems and require various breathing support devices for facilitating artificial breathing and preventing respiratory disorders, including newborn respiratory distress syndrome (RDS). Other factors, such as the increasing healthcare expenditure and the development of miniature devices are projected to drive the market further. Significant efforts by both the government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all, along with developing new and improving the existing healthcare infrastructure are also creating a positive outlook for the market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global respiratory care devices market report, along with forecasts at the global and regional level from 2024-2032. The report has categorized the market based on product, indication and end-user.Breakup by Product:
- Therapeutic Devices
- Positive Airway Pressure (PAP) Devices
- Ventilators
- Nebulizers
- Humidifiers
- Inhalers
- Other
- Monitoring Devices
- Pulse Oximeters
- Gas Analyzers
- Others
- Diagnostic Devices
- Spirometers
- Polysomnography Devices
- Peak Flow Meters
- Others
- Consumables and Accessories
- Masks
- Disposable Resuscitators
- Breathing Circuits
- Tracheostomy Tubes
- Nasal Cannulas
- Others
Breakup by Indication:
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Sleep Apnea
- Infectious Disease
- Others
Breakup by End-User:
- Hospitals
- Home Care Settings
- Ambulatory Care Centers
- Others
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Competitive Landscape:
- The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, ResMed, Chart Industries Inc., Hamilton Medical, Medtronic, Masimo, Drägerwerk, Invacare Corporation, Allied Healthcare Products Inc, 3B Medical Inc., Air Liquide, Fisher & Paykel Healthcare, GE Healthcare, Vyaire Medical Inc., Rotech Healthcare Inc., etc.
Key Questions Answered in This Report:
- How has the global respiratory care devices market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global respiratory care devices industry?
- What has been the impact of COVID-19 on the global respiratory care devices industry?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global respiratory care devices industry?
- What are the key driving factors and challenges in the global respiratory care devices industry?
- What is the structure of the global respiratory care devices industry and who are the key players?
- What is the degree of competition in the global respiratory care devices industry?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis
2 Scope and Methodology
4 Introduction
5 Global Respiratory Care Devices Market
6 Market Breakup by Product
7 Market Breakup by Indication
8 Market Breakup by End-User
9 Market Breakup by Region
10 SWOT Analysis
12 Porter’s Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Philips Healthcare
- ResMed
- Chart Industries Inc.
- Hamilton Medical
- Medtronic
- Masimo
- Drägerwerk
- Invacare Corporation
- Allied Healthcare Products Inc
- 3B Medical Inc.
- Air Liquide
- Fisher & Paykel Healthcare
- GE Healthcare
- Vyaire Medical Inc.
- Rotech Healthcare Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 146 |
| Published | March 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 21.9 Billion |
| Forecasted Market Value ( USD | $ 42.4 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
